DPD deficiency in an Irish oncology centre: Prevalence and clinical implications.

Ruth KieranTaylor MitchellAfrah Al FazariAleena ChinoyCarolyn MoloneyJohn McCaffrey

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

Approximately 6.8% of Irish patients may carry DPD deficiencies, prospective screening is essential to reduce the risk of life-threatening toxicity in these patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
oxidative stress
primary care
general practice